首页> Clinical breast cancer> A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).

导出原文传递

翻译打印收藏纠错

第一作者： Henry L,Gómez

第一单位： Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.

作者： Henry L,Gómez ^[1] ; Silvia,Neciosup ^[1] ; Célia,Tosello ^[2] ; Max,Mano ^[3] ; José,Bines ^[4] ; Gustavo,Ismael ^[5] ; Patrícia X,Santi ^[6] ; Hélio,Pinczowski ^[6] ; Yeni,Nerón ^[7] ; Marcello,Fanelli ^[8] ; Luis,Fein ^[9] ; Carlos,Sampaio ^[10] ; Guillermo,Lerzo ^[11] ; Adolfo,Capó ^[12] ; Juan J,Zarba ^[13] ; César,Blajman ^[14] ; Mirta S,Varela ^[15] ; Jeovany,Martínez-Mesa ^[16] ; Gustavo,Werutsky ^[17] ; Carlos H,Barrios ^[18]

作者单位： Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. ^[1] Instituto Brasileiro de Controle do Câncer, São Paulo, São Paulo, Brazil. ^[2] Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, São Paulo, Brazil. ^[3] Instituto Nacional de Câncer, Rio de Janeiro, Brazil. ^[4] Fundação Doutor Amaral Carvalho, Jaú, Brazil. ^[5] Instituto de Ensino e Pesquisa São Lucas, Santo André, Brazil. ^[6] Centro de Pesquisas Oncológicas de Santa Catarina, Florianópolis, Brazil. ^[7] Hospital A.C. Camargo, São Paulo, Brazil. ^[8] Centro Oncológico de Rosário, Rosário, Argentina. ^[9] Clínica Amo, Salvador, Brazil. ^[10] Investigaciones Clínicas Ciudad de Buenos Aires, Buenos Aires, Argentina. ^[11] Fundación Centro Oncológico de Integración Regional, Mendoza, Argentina. ^[12] Centro San Roque, Tucumán, Argentina. ^[13] ISIS Clínica Especializada, Santa Fé, Argentina. ^[14] CER Instituto Médico, Buenos Aires, Argentina. ^[15] Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. ^[16] Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. Electronic address: gustavo.werutsky@lacog.org.br. ^[17] Pontifical Catholic University of Rio Grande do Sul School of Medicine, Hospital São Lucas, Porto Alegre, Brazil. ^[18]

关键词 Chemotherapy Human epidermal growth factor receptor 2-positive Lapatinib Metastatic breast cancer Treatment outcome